Livac Team

Our Team

Our vision is to minimise the invasiveness of surgery requiring liver retraction, and to contribute meaningfully to technical innovations in this field. The LiVac team is a group of highly skilled specialists all bringing to the table vital expertise, including management, commercialization, legal and production knowledge.

Dr Philip Gan

Founding Director and Chief Medical Officer

Dr Philip Gan is the Chief Medical Officer and founding director of Livac Pty Ltd.

Dr Gan gained his medical degree through the University of Melbourne in 1991 and became a Fellow of the Royal Australasian College of Surgeons in 2001. Dr Gan is a consultant general surgeon at the St John of God and Southwest Healthcare Hospitals, Warrnambool.

His area of interest is in minimally invasive laparoscopic surgery, including laparoscopic colorectal resections, hernia repairs, cholecystectomy, bariatric surgery, fundoplication and splenectomy (largest 2.6kg).

Dr Gan has been performing single port cholecystectomies since 2012. His aim in reducing the number of incisions required in laparoscopic surgery was a key driver in developing the LiVac Retractor.

Jonathan Gan

Board Member

Jonathan has more than 20 years experience in the finance industry, and is the Founder and Managing Director of Bluehive Financial Services.

He has strong expertise across all financial areas, and is highly recognised in the industry having received numerous accolades and awards from Mortgage & Finance Association of Australia (MFAA), Australian Finance Group (AFG) and Australian Mortgage Awards (AMA).

Jonathan holds a Bachelor of Business (Accountancy) from RMIT University and a Diploma in Financial Services (Finance/Mortgage Broking). Jonathan also completed his REIV Estate Agents Representative Certificate and is able to assist his clients as a buyer’s advocate.

​

Patrick Baker

Board Member

Patrick Baker is the Group Director, Philanthropy and Health Innovation at Alfred Health, where he leads the strategic direction of philanthropic engagement and health innovation across the organisation. In this role, Patrick oversees The Alfred Foundation and works closely with clinical and research leaders to align donor support with projects that drive transformative impact in patient care, medical research, and health system innovation.

With tertiary qualifications in business and leadership, Patrick brings extensive experience in strategic leadership, stakeholder engagement, and health sector advancement. He has been instrumental in securing significant philanthropic investment to support cutting-edge initiatives that improve outcomes for patients and communities.

He currently serves on the boards of Cancer Council Victoria, The Bays Hospital, the Mornington Peninsula Foundation, the Melanoma and Skin Cancer Trials Group and Livac. These appointments reflect his deep commitment to improving health through collaboration, research, and community-focused initiatives.

Cameron Peacock

Director

Cameron Peacock holds a Bachelor of Commerce Degree from the University of Western Australia, a Graduate Diploma in Applied Finance and Investment from FINSIA and a Masters in Applied Finance from the University of Melbourne.  Cameron has over 25 years in corporate finance and investor relations, with extensive ASX capital markets experience.

He was previously Head of Investor Relations & Business Development at Nickel Industries Limited. He is a former senior executive at Santana Minerals Ltd, and Alpha HPA Limited, where he also served as Non-Executive Director. He brings deep engagement with institutional investors and capital markets networks.

Mr Peacock is currently a Non-Executive Director of ASX-listed FMR Resources Limited.

Esther Apos

Quality & Regulatory Manager

Dr Esther Apos completed her Ph.D in Biochemistry in 1992 through the Faculty of Veterinary Science at the University of Melbourne. Over the past twenty years, she has worked in academic and commercial research, pharmaceutical and medical device product development, clinical trials, and regulatory compliance and affairs. Dr Apos has worked with numerous biotech, medical device and cosmetic companies, developing their product documentation and dossier registration.

Dr Paul Warden-Hutton

Patent Attorney

Paul holds a B.Biomed.Sc. majoring in Chemistry and Biochemistry. His B.Biomed.Sci.(Hons) year was his introduction to applied research and he continued his research in the completion of a Ph.D. in Biophysics in which he performed spectroscopic, computational and informatic studies of the prion protein.

In 2003, Paul started in the Intellectual Property Profession when he joined a Japanese Patent Attorney Firm in Osaka. Paul provided advice to Japanese & non-Japanese IP Owners in relation to Japanese, US & EP Patent Law. With his physics, computational and biochemistry backgrounds, Paul worked in both the Firm’s Information Technology and Life Sciences and teams.

Paul is a Registered Australian and New Zealand Patent & Trade Mark Attorney with a Masters in Intellectual Property Law.

Paul’s practice includes drafting, prosecution and litigation of Engineering, Spectroscopic, Medical Imaging, Sensor-technologies, Clean Technology, Mechanical, Computer Software, Biophysical and Material Science matters and Plant Breeder Rights before the Australian and New Zealand Patent Offices. With his background in applied research, Paul’s work covers most technology areas including pneumatics, medical devices, chemical processing, anaesthesia/sleep monitoring devices, safety devices, building materials and business methods.

Paul is a Member of the Asian Patent Attorney Association, The Intellectual Property Society of Australia and New Zealand, The Royal Australian Chemical Institute and a Fellow of The Institute of Patent and Trade Mark Attorneys of Australia.